CAP TODAY/Thermo Fisher Scientific Webinar: Next-Generation Sequencing: An Emerging Technique for Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia

Thank you

This live web event has ended. Thank you for attending.

Description

Next-Generation Sequencing:
An Emerging Technique For Measurable Residual
Disease (MRD) Detection In Acute Myeloid Leukemia

Why should you register now for this webinar?
Hear a national thought leader discuss the latest research on MRD in acute
myeloid leukemia and techniques for MRD detection.
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenter: Jerald Radich, MD

What will this webinar empower you to do?

• Identify the implications of MRD in disease progression, prognosis and therapy selection
• Evaluate the challenges of traditional MRD testing methods
• Understand the medical guidelines and why NGS is emerging as a powerful technique for MRD detection
• Ask questions of our distinguished presenter